Univest
Univest
  • Markets

Sree Rayalaseema Hi-Strength Hypo Share Price Target 2026 Analyst Forecast Bull and Bear Case

  • July 3, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Sree Rayalaseema Hi-Strength Hypo Share Price Target 2026

Sree Rayalaseema Hi-Strength Hypo CMP Rs 489. 52W High Rs 717 | Low Rs 381. Mcap Rs 836 Cr. 12M Target Rs 660. PE: 9.28.

The Sree Rayalaseema Hi-Strength Hypo share price target stands at Rs 660 for 2026, implying approximately 35% upside from the current market price of Rs 489. The stock trades at a price-to-earnings ratio of 9.28x, reflecting attractive value versus sector peers, with a market capitalisation of Rs 836 Cr. Investors tracking the specialty chemicals segment are closely watching Sree Rayalaseema Hi-Strength Hypo as an emerging opportunity given its 52-week range of Rs 381 to Rs 717. This analysis covers the bull case, bear case, and key catalysts that will define the Sree Rayalaseema Hi-Strength Hypo share price target trajectory through 2026.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Sree Rayalaseema Hi-Strength Hypo Company Overview and Key Metrics
  • Why Is the Sree Rayalaseema Hi-Strength Hypo share price target Set at Rs 660 for 2026
    • FY27 Earnings Delivery and Revenue Acceleration
    • China Plus One Beneficiary
    • Domestic Agrochemical Demand Cycle
    • RBI Rate Cut Cycle and Lower Cost of Capital
    • Union Budget 2026 and Policy Tailwinds
  • Sree Rayalaseema Hi-Strength Hypo Share Price Target Short Term, 12 Month and Long Term
    • Short Term Sree Rayalaseema Hi-Strength Hypo Share Price Target: 3 to 6 Months
    • 12 Month Sree Rayalaseema Hi-Strength Hypo Share Price Target 2026
    • Long Term Sree Rayalaseema Hi-Strength Hypo Share Price Target: FY27 to FY28
  • Bull Case and Bear Case for Sree Rayalaseema Hi-Strength Hypo Share Price Target
    • Bull Case: Rs 760
    • Bear Case: Rs 530
  • Key Risks to the Sree Rayalaseema Hi-Strength Hypo Share Price Target 2026
    • Macro Headwind from Global Slowdown and US Tariff Policy
    • Valuation Risk and Earnings Miss Scenario
    • Competitive Pressure in the Specialty Chemicals Segment
    • FII Selling and Broader Market Volatility
  • How to Invest in Sree Rayalaseema Hi-Strength Hypo Stock
  • Conclusion
  • FAQs on Sree Rayalaseema Hi-Strength Hypo Share Price Target 2026
    • What is the Sree Rayalaseema Hi-Strength Hypo share price target for 2026?
    • Is Sree Rayalaseema Hi-Strength Hypo a good stock to buy right now?
    • What is Sree Rayalaseema Hi-Strength Hypo’s 52-week high and low?
    • What is the market cap of Sree Rayalaseema Hi-Strength Hypo?
    • What are the key risks to the Sree Rayalaseema Hi-Strength Hypo share price target?
    • What is the bull case target for Sree Rayalaseema Hi-Strength Hypo in 2026?
    • Where can I track Sree Rayalaseema Hi-Strength Hypo share price live?
    • How do I invest in Sree Rayalaseema Hi-Strength Hypo stock?

Sree Rayalaseema Hi-Strength Hypo Company Overview and Key Metrics

Sree Rayalaseema Hi-Strength Hypo Details
NSE Symbol SRHHYPOLTD
Sector Specialty Chemicals
CMP (Rs) 489
52W High (Rs) 717
52W Low (Rs) 381
Market Cap (Rs Cr) 836 Cr
P/E Ratio 9.28
12M Target (Rs) 660
Bull Case (Rs) 760
Bear Case (Rs) 530

Sree Rayalaseema Hi-Strength Hypo is a specialty chemicals company listed on the National Stock Exchange (NSE: SRHHYPOLTD). With a market capitalisation of Rs 836 Cr, the company occupies a defined position in the Indian specialty chemicals landscape. The stock has traded in a wide range over the past 12 months, touching a high of Rs 717 and a low of Rs 381, before arriving at its current level of Rs 489. Uniresearch analysts project a 12-month Sree Rayalaseema Hi-Strength Hypo share price target of Rs 660, with a bull case of Rs 760 and a bear case of Rs 530.

Why Is the Sree Rayalaseema Hi-Strength Hypo share price target Set at Rs 660 for 2026

FY27 Earnings Delivery and Revenue Acceleration

The Sree Rayalaseema Hi-Strength Hypo share price target of Rs 660 is anchored in expectations of FY27 earnings delivery. At a P/E of 9.28x on trailing earnings, the stock is attractively valued. Consistent revenue growth and margin improvement in coming quarters can re-rate the stock towards the Rs 660 target.

China Plus One Beneficiary

Global chemical companies are actively diversifying supply chains away from China, creating significant opportunity for Indian chemical manufacturers. The shift is accelerating as buyers seek supply security and quality compliance from alternative vendors.

Domestic Agrochemical Demand Cycle

India’s agrochemical market benefits from monsoon-driven crop protection demand cycles. A normal monsoon with adequate rainfall can boost pesticide, herbicide, and fertiliser volumes significantly in the second half of the fiscal year.

RBI Rate Cut Cycle and Lower Cost of Capital

The Reserve Bank of India has shifted to an accommodative monetary policy stance, with rate cuts reducing borrowing costs across the economy. For Sree Rayalaseema Hi-Strength Hypo, lower interest rates translate to reduced finance costs and potentially higher consumer demand in its end markets, creating a favourable backdrop for the Sree Rayalaseema Hi-Strength Hypo share price target to materialise by year-end.

Union Budget 2026 and Policy Tailwinds

The Union Budget 2026-27 has maintained strong capex allocation of Rs 11 lakh crore for infrastructure, directly benefiting sectors including specialty chemicals. Tax rationalisation and sector-specific policy support create a constructive policy environment that supports the Sree Rayalaseema Hi-Strength Hypo share price target thesis through improved demand visibility.

Sree Rayalaseema Hi-Strength Hypo Share Price Target Short Term, 12 Month and Long Term

Short Term Sree Rayalaseema Hi-Strength Hypo Share Price Target: 3 to 6 Months

In the near term, the Sree Rayalaseema Hi-Strength Hypo share price target for the next 3 to 6 months is pegged at Rs 530, contingent on Q1 FY27 earnings meeting expectations and sustained buying interest in the specialty chemicals segment. Technically, the stock needs to hold the Rs 400-419 zone for this short-term target to remain valid.

12 Month Sree Rayalaseema Hi-Strength Hypo Share Price Target 2026

Our 12-month Sree Rayalaseema Hi-Strength Hypo share price target is Rs 660. This target is based on the Uniresearch fundamental estimate, which factors in FY27 revenue growth, margin normalisation, and sector re-rating potential. The Rs 660 level represents approximately 35% upside from the current price of Rs 489.

Long Term Sree Rayalaseema Hi-Strength Hypo Share Price Target: FY27 to FY28

Over a 2 to 3 year horizon, the long-term Sree Rayalaseema Hi-Strength Hypo share price target is estimated between Rs 759 and Rs 891, assuming continued compounding in earnings, potential capacity expansions, and improved market positioning. Investors with a multi-year holding perspective may find the current CMP of Rs 489 an attractive accumulation level.

Bull Case and Bear Case for Sree Rayalaseema Hi-Strength Hypo Share Price Target

Bull Case: Rs 760

In the bull case scenario, Sree Rayalaseema Hi-Strength Hypo delivers above-estimate earnings growth driven by strong demand, margin expansion, and new business wins. If these catalysts materialise simultaneously, the Sree Rayalaseema Hi-Strength Hypo share price target could reach Rs 760, implying approximately 55% upside from the current market price.

Bear Case: Rs 530

The bear case of Rs 530 assumes earnings disappointment, sector-level de-rating, or broader market selloff driven by FII outflows. In this scenario, Sree Rayalaseema Hi-Strength Hypo could re-test support levels closer to its 52-week low of Rs 381, representing a downside risk investors should monitor.

Scenario Target Price (Rs) Upside/Downside from CMP Key Assumption
Bull Case 760 55% Strong earnings growth, sector re-rating
Base Case 660 35% Steady earnings, margin improvement
Bear Case 530 8% Earnings miss, macro headwinds

Key Risks to the Sree Rayalaseema Hi-Strength Hypo Share Price Target 2026

Macro Headwind from Global Slowdown and US Tariff Policy

A sharper-than-expected global slowdown or escalation in US-China trade tensions could dampen demand across sectors. Sree Rayalaseema Hi-Strength Hypo faces indirect risk if its customers or supply chain partners are impacted by slower global growth, as this could translate to lower order volumes or pricing pressure.

Valuation Risk and Earnings Miss Scenario

If Sree Rayalaseema Hi-Strength Hypo reports quarterly earnings below analyst estimates or provides weak forward guidance, the stock could see significant de-rating. Elevated valuations in some segments leave limited margin for error, making execution risk a critical near-term concern.

Competitive Pressure in the Specialty Chemicals Segment

The specialty chemicals space in India is increasingly competitive with both domestic players and global companies vying for market share. Price competition, product commoditisation, or loss of key client contracts could pressure Sree Rayalaseema Hi-Strength Hypo’s revenue trajectory.

FII Selling and Broader Market Volatility

Foreign Institutional Investor selling in Indian equities has historically led to broad-based price corrections even in fundamentally sound companies. Sree Rayalaseema Hi-Strength Hypo’s share price could face near-term pressure if FII sentiment turns risk-off due to global monetary policy changes.

How to Invest in Sree Rayalaseema Hi-Strength Hypo Stock

Step 1: Research and Fundamental Analysis. Before investing, thoroughly review Sree Rayalaseema Hi-Strength Hypo’s quarterly results, annual report, and management commentary. Focus on revenue growth trajectory, operating margin trends, and debt levels to assess whether the Sree Rayalaseema Hi-Strength Hypo share price target of Rs 660 is achievable.

Step 2: Use Stock Screeners for Live Data.

Check Sree Rayalaseema Hi-Strength Hypo Live Data on Univest Screener

Monitor key metrics including P/E, return on equity, and promoter holding changes. These ratios can confirm or challenge the Sree Rayalaseema Hi-Strength Hypo share price target thesis in real time.

Step 3: Define Your Entry Zone. The current CMP of Rs 489 is within the identified accumulation zone based on the 52-week low of Rs 381 and the Uniresearch target of Rs 660. Consider entering in tranches to average your cost over market fluctuations.

Step 4: Set Stop Loss and Risk Management Levels. Always define a stop-loss level before investing. A prudent stop-loss for Sree Rayalaseema Hi-Strength Hypo based on the current technical setup would be in the Rs 430 to Rs 450 range. Never risk more than 2-5% of your portfolio in any single position.

Step 5: Open a Zero-Brokerage Demat Account. To invest in Sree Rayalaseema Hi-Strength Hypo at zero brokerage, open your demat account with Univest, which combines SEBI-registered research with integrated trading. This allows you to act on the Sree Rayalaseema Hi-Strength Hypo share price target analysis without incurring unnecessary transaction costs.

Download the Univest iOS App or Univest Android App to track Sree Rayalaseema Hi-Strength Hypo live price and get daily stock recommendations.

Conclusion

The Sree Rayalaseema Hi-Strength Hypo share price target for 2026 is Rs 660, with a bull case of Rs 760 and a bear case of Rs 530, based on Uniresearch estimates as of 29 June 2026. At a CMP of Rs 489 with a 52-week range of Rs 381 to Rs 717, Sree Rayalaseema Hi-Strength Hypo presents a risk-reward opportunity that warrants monitoring. Investors should review Q1 FY27 results, track management commentary on guidance, and consult a SEBI-registered advisor before making investment decisions. The Sree Rayalaseema Hi-Strength Hypo share price target outlined here is for educational purposes only.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on Sree Rayalaseema Hi-Strength Hypo Share Price Target 2026

What is the Sree Rayalaseema Hi-Strength Hypo share price target for 2026?

Ans. The Sree Rayalaseema Hi-Strength Hypo share price target for 2026, as per Uniresearch estimate, is Rs 660. This implies approximately 35% upside from the current market price of Rs 489.

Is Sree Rayalaseema Hi-Strength Hypo a good stock to buy right now?

Ans. Whether Sree Rayalaseema Hi-Strength Hypo is a good buy depends on your investment horizon, risk appetite, and portfolio allocation. The Uniresearch Sree Rayalaseema Hi-Strength Hypo share price target of Rs 660 implies meaningful upside, but investors must assess company fundamentals and market conditions before investing.

What is Sree Rayalaseema Hi-Strength Hypo’s 52-week high and low?

Ans. Sree Rayalaseema Hi-Strength Hypo’s 52-week high is Rs 717 and the 52-week low is Rs 381, as of 29 June 2026. The current price of Rs 489 represents a 28% gain from the 52-week low.

What is the market cap of Sree Rayalaseema Hi-Strength Hypo?

Ans. The market capitalisation of Sree Rayalaseema Hi-Strength Hypo is approximately Rs 836 Cr, as of 29 June 2026.

What are the key risks to the Sree Rayalaseema Hi-Strength Hypo share price target?

Ans. Key risks to the Sree Rayalaseema Hi-Strength Hypo share price target of Rs 660 include earnings disappointment, global macro headwinds, FII selling pressure, and competitive intensity in the specialty chemicals sector. Any of these factors could delay or reduce the target realisation.

What is the bull case target for Sree Rayalaseema Hi-Strength Hypo in 2026?

Ans. In the bull case scenario, the Sree Rayalaseema Hi-Strength Hypo share price target could reach Rs 760, implying approximately 55% upside from the current level. This assumes stronger-than-expected earnings growth and sector re-rating.

Where can I track Sree Rayalaseema Hi-Strength Hypo share price live?

Ans. You can track Sree Rayalaseema Hi-Strength Hypo (NSE: SRHHYPOLTD) live price, charts, and fundamental data on the Univest app or screener. The Univest platform provides real-time price data, analyst research, and portfolio tracking in one place.

How do I invest in Sree Rayalaseema Hi-Strength Hypo stock?

Ans. To invest in Sree Rayalaseema Hi-Strength Hypo, open a demat account with a SEBI-registered broker like Univest, which offers zero brokerage and integrated research. Search for the ticker SRHHYPOLTD on NSE, review fundamentals using the Univest Screener, and invest based on your financial goals and risk profile.



News
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply